Baseline CD4 + and expansion of γδ T cells correlate with response to durvalumab in triple-negative breast cancer patients.
Barbara SeligerThomas KarnKarsten WeberAndreas SchneeweissClaus HanuschJens Uwe BlohmerDirk-Michael ZahmChristian JackischMarion van MackelenberghJörg ThomallaFrederik MarméJens HuoberVolkmar MüllerChristian SchemAnja MüllerElmar StickelerKatharina BiehlPeter A FaschingMichael UntchSibylle LoiblCarsten DenkertBarbara SeligerPublished in: Clinical and translational medicine (2024)
Keyphrases